Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021)
Patrik Olekšák, Eugenie Nepovimová, Žofia Chrienová, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114498-114498
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases
Christopher Huynh, Jaewhee Ryu, Jooho Lee, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 102-122
Closed Access | Times Cited: 53
Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents
Maria Antonietta Occhiuzzi, Gernando Lico, Giuseppina Ioele, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114971-114971
Closed Access | Times Cited: 43
Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies
Liyao Zheng, Shipei He, Hong Wang, et al.
Aging and Disease (2024)
Open Access | Times Cited: 12
mTOR in metabolic homeostasis and disease
Xuejia Liu, Bin Guo, Qiye Li, et al.
Experimental Cell Research (2024) Vol. 441, Iss. 2, pp. 114173-114173
Closed Access | Times Cited: 9
mTOR Variants Activation Discovers PI3K-like Cryptic Pocket, Expanding Allosteric, Mutant-Selective Inhibitor Designs
Yonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
Journal of Chemical Information and Modeling (2025)
Open Access | Times Cited: 1
Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
Abdelhakim Bouyahya, Aicha El Allam, Sara Aboulaghras, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5520-5520
Open Access | Times Cited: 36
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 3, pp. 141-158
Closed Access | Times Cited: 7
Autophagy modulation in cancer therapy: Challenges coexist with opportunities
Yongya Wu, Aoxue Wang, Guotai Feng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116688-116688
Closed Access | Times Cited: 6
Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
Xueqin Huang, Li You, Eugenie Nepovimová, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization
Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, et al.
Chemical Science (2023) Vol. 15, Iss. 3, pp. 1003-1017
Open Access | Times Cited: 14
Discovery of highly potent mTOR inhibitors aimed at suppressing the progression of acute myeloid leukemia
Yuanyuan Li, Han Qiu, Qiwen Sun, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108287-108287
Closed Access
Chloroquine Enhances Chemosensitivity of Breast Cancer via mTOR Inhibition
Zhuo Lin, Yuting Xu, Mifang Li, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 948-948
Open Access
The E3 Ligase NEDD4L Prevents Colorectal Cancer Liver Metastasis via Degradation of PRMT5 to Inhibit the AKT/mTOR Signaling Pathway
Zhewen Dong, Xiaofei She, Junxian Ma, et al.
Advanced Science (2025)
Open Access
Substituents introduction of methyl and methoxy functional groups on resveratrol stabilizes mTOR binding for autophagic cell death induction
Zin Zin, Satapat Racha, Preedakorn Chunhacha, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy
Prakash Kumar Senapati, Kewal Kumar Mahapatra, Amruta Singh, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189342-189342
Closed Access
Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
Rémi Kinet, Benjamin Dehay
Cells (2023) Vol. 12, Iss. 4, pp. 621-621
Open Access | Times Cited: 9
Novel 5-aminopyrazoles endowed with anti-angiogenetic properties: Design, synthesis and biological evaluation
Matteo Lusardi, Bernhard Wehrle‐Haller, Adama Sidibé, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115727-115727
Open Access | Times Cited: 9
Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway
Shaoling Lin, Shengxi Zhang, Angyu Zhan, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176395-176395
Closed Access | Times Cited: 3
Metformin derivatives – Researchers’ friends or foes?
Sema Tuna Torunoglu, Agnieszka Zajda, Janne Tampio, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115743-115743
Open Access | Times Cited: 8
Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective
Lucinda J. Berglund
Journal of Clinical Immunology (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 8
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics
Žofia Chrienová, David Rysanek, Patrik Olekšák, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 10
Frentizole derivatives with mTOR inhibiting and senomorphic properties
Žofia Chrienová, David Rysanek, Josef Novák, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115600-115600
Open Access | Times Cited: 5
Global Collaboration in Technology Sectors during the COVID-19 Pandemic: A Patent Review
Eunsook Jeon, Kyungkook Kim, Hyunjeong Park, et al.
Sustainability (2023) Vol. 15, Iss. 15, pp. 11831-11831
Open Access | Times Cited: 2
Organocatalyzed Double C(sp3)−H Alkylation of Cyclic N‐Sulfonyl Ketimines with 3‐Chloropropiophenones: Selective Access to 2,3,6‐Trisubstituted Pyridines
Ashvani K. Patel, Sampak Samanta
European Journal of Organic Chemistry (2023) Vol. 26, Iss. 33
Closed Access | Times Cited: 1
Concerning Newborn Rashes and Developmental Abnormalities: Part II: Congenital Infections, Ichthyosis, Neurocutaneous Disorders, Vascular Malformations, and Midline Lesions
Lily Park, Sophia Reyes-Hadsall, Rummit K. Dhillon, et al.
Pediatrics in Review (2023) Vol. 44, Iss. 8, pp. 447-465
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top